AstraZeneca Appoints Iskra Reic as New International Operations Leader Amid Leon Wang Investigation in China

Iskra Reic has been appointed as AstraZeneca's Executive Vice President of International Operations in light of the investigation involving Leon Wang, the former international chief. Reic, who has been part of AstraZeneca since 2001, will manage and oversee strategic operations across several regions including China, Asia, Eurasia, Africa, Latin America, Australia, New Zealand, and the Middle East[1][2]. Alongside her ongoing role as Senior Vice President for Vaccines and Immune Therapies, she will relocate to Shanghai and focus on strategic oversight and market growth outside of the U.S., particularly in key regions like the Middle East, Africa, and Asia. Her extensive experience, especially in the fields of COVID-19 and RSV vaccines along with her capability for improving patient access to innovative medicines, is expected to advance AstraZeneca's international reach and bolster its operational strength[1][2].